Literature DB >> 28893975

Agonist-Dependent and -Independent κ Opioid Receptor Phosphorylation: Distinct Phosphorylation Patterns and Different Cellular Outcomes.

Yi-Ting Chiu1, Chongguang Chen1, Daohai Yu1, Stefan Schulz1, Lee-Yuan Liu-Chen2.   

Abstract

We reported previously that the selective agonist U50,488H promoted phosphorylation of the mouse κ opioid receptor (KOPR) at residues S356, T357, T363, and S369. Here, we found that agonist (U50,488H)-dependent KOPR phosphorylation at all the residues was mediated by Gi/o α proteins and multiple protein kinases [GRK2, GRK3, GRK5, GRK6 and protein kinase C (PKC)]. In addition, PKC activation by phorbol ester induced agonist-independent KOPR phosphorylation. Compared with U50,488H, PKC activation promoted much higher S356/T357 phosphorylation, much lower T363 phosphorylation, and similar levels of S369 phosphorylation. After U50,488H treatment, GRKs, but not PKC, were involved in agonist-induced KOPR internalization. In contrast, PKC activation caused a lower level of agonist-independent KOPR internalization, compared with U50,488H. U50,488H-induced activation of extracellular signal-regulated kinase 1/2 (ERK1/2) was G protein-, but not β-arrestin-, dependent. After U50,488H treatment, GRK-mediated, but not PKC-mediated, KOPR phosphorylation followed by β-arrestin recruitment desensitized U50,488H-induced ERK1/2 response. Therefore, agonist-dependent (GRK- and PKC-mediated) and agonist-independent (PKC-promoted) KOPR phosphorylations show distinct phosphorylation patterns, leading to diverse cellular outcomes.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28893975      PMCID: PMC5635518          DOI: 10.1124/mol.117.108555

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  37 in total

1.  Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells.

Authors:  Christian Doll; Florian Pöll; Kenneth Peuker; Anastasia Loktev; Laura Glück; Stefan Schulz
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

2.  Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal.

Authors:  F Simonin; O Valverde; C Smadja; S Slowe; I Kitchen; A Dierich; M Le Meur; B P Roques; R Maldonado; B L Kieffer
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

Review 3.  The potential for isoenzyme-selective modulation of protein kinase C.

Authors:  J Hofmann
Journal:  FASEB J       Date:  1997-07       Impact factor: 5.191

4.  Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade.

Authors:  L M Bohn; M M Belcheva; C J Coscia
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

5.  Mechanisms of homologous and heterologous phosphorylation of FFA receptor 4 (GPR120): GRK6 and PKC mediate phosphorylation of Thr³⁴⁷, Ser³⁵⁰, and Ser³⁵⁷ in the C-terminal tail.

Authors:  Rebecca N Burns; Monalisa Singh; Ilya S Senatorov; Nader H Moniri
Journal:  Biochem Pharmacol       Date:  2014-01-08       Impact factor: 5.858

Review 6.  Molecular mechanisms of opioid receptor-dependent signaling and behavior.

Authors:  Ream Al-Hasani; Michael R Bruchas
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

Review 7.  Agonist-induced regulation and trafficking of kappa opioid receptors.

Authors:  Lee-Yuan Liu-Chen
Journal:  Life Sci       Date:  2004-06-18       Impact factor: 5.037

8.  Role of G Protein-Coupled Receptor Kinases 2 and 3 in μ-Opioid Receptor Desensitization and Internalization.

Authors:  Janet D Lowe; Helen S Sanderson; Alexandra E Cooke; Mehrnoosh Ostovar; Elena Tsisanova; Sarah L Withey; Charles Chavkin; Stephen M Husbands; Eamonn Kelly; Graeme Henderson; Chris P Bailey
Journal:  Mol Pharmacol       Date:  2015-05-26       Impact factor: 4.436

Review 9.  Physiological role of G-protein coupled receptor phosphorylation.

Authors:  Adrian J Butcher; Kok Choi Kong; Rudi Prihandoko; Andrew B Tobin
Journal:  Handb Exp Pharmacol       Date:  2012

10.  Identification of phosphorylation sites in the COOH-terminal tail of the μ-opioid receptor.

Authors:  Ying-Ju Chen; Sue Oldfield; Adrian J Butcher; Andrew B Tobin; Kunal Saxena; Vsevolod V Gurevich; Jeffrey L Benovic; Graeme Henderson; Eamonn Kelly
Journal:  J Neurochem       Date:  2012-11-30       Impact factor: 5.372

View more
  10 in total

Review 1.  Post-translational Modifications of Opioid Receptors.

Authors:  Mariana Lemos Duarte; Lakshmi A Devi
Journal:  Trends Neurosci       Date:  2020-04-16       Impact factor: 13.837

Review 2.  Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects.

Authors:  Kelly F Paton; Diana V Atigari; Sophia Kaska; Thomas Prisinzano; Bronwyn M Kivell
Journal:  J Pharmacol Exp Ther       Date:  2020-09-10       Impact factor: 4.030

3.  Kappa Opioid Receptor Expression and Function in Cells of the Immune System.

Authors:  Thomas J Rogers
Journal:  Handb Exp Pharmacol       Date:  2022

4.  Fundamentals of the Dynorphins/Kappa Opioid Receptor System: From Distribution to Signaling and Function.

Authors:  Catherine Cahill; Hugo A Tejeda; Mariana Spetea; Chongguang Chen; Lee-Yuan Liu-Chen
Journal:  Handb Exp Pharmacol       Date:  2022

Review 5.  The Role of G Protein-coupled Receptor Kinases in Cancer.

Authors:  Shan Yu; Litao Sun; Yufei Jiao; Leo Tsz On Lee
Journal:  Int J Biol Sci       Date:  2018-02-05       Impact factor: 6.580

6.  Compartment-specific opioid receptor signaling is selectively modulated by different dynorphin peptides.

Authors:  Jennifer M Kunselman; Achla Gupta; Ivone Gomes; Lakshmi A Devi; Manojkumar A Puthenveedu
Journal:  Elife       Date:  2021-04-28       Impact factor: 8.140

7.  Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands.

Authors:  Chiara Sturaro; Davide Malfacini; Michela Argentieri; Francine M Djeujo; Erika Marzola; Valentina Albanese; Chiara Ruzza; Remo Guerrini; Girolamo Calo'; Paola Molinari
Journal:  Front Pharmacol       Date:  2022-04-21       Impact factor: 5.988

8.  Pharmacological and phosphoproteomic approaches to roles of protein kinase C in kappa opioid receptor-mediated effects in mice.

Authors:  Jeffrey J Liu; Yi-Ting Chiu; Chongguang Chen; Peng Huang; Matthias Mann; Lee-Yuan Liu-Chen
Journal:  Neuropharmacology       Date:  2020-09-22       Impact factor: 5.250

9.  Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells.

Authors:  Miriam Stoeber; Damien Jullié; Joy Li; Soumen Chakraborty; Susruta Majumdar; Nevin A Lambert; Aashish Manglik; Mark von Zastrow
Journal:  Elife       Date:  2020-02-25       Impact factor: 8.140

Review 10.  GRKs as Key Modulators of Opioid Receptor Function.

Authors:  Laura Lemel; J Robert Lane; Meritxell Canals
Journal:  Cells       Date:  2020-11-02       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.